Potential take over target, page-18

DrS777 makes some pertinent points regarding the potential of AVH, particularly the company "has revolutionary medical technology with FDA approval and many years of results in the current burns space", dating back to the Bali bombings of 2002, when several burns victims were treated.

Also, the fact AVH has FDA approval for some of its work puts it streets ahead of potential rival products.

So posters should carefully read the market releases from AVH to understand there is still research to be undertaken on such conditions as vitiligo, for example, for which AVH has a 2023 timeline for completion of the study.

Posters should also accept AVH is till a start - up medical technology company and it's going to be a little while yet before it rewards shareholders with significant share market appreciation.

I have held this stock for nearly 20 years with an average buy - in price of $2.00, such is my belief in the technology.